Ask AI

The Cough That Won’t Quit: Evolving Management of Refractory Chronic Cough

Refractory chronic cough (RCC) is a prevalent but underrecognized condition, with diagnostic complexities, debilitating effects on patients’ lives, and limited treatment options. Emerging insights into the neurogenic pathophysiology of RCC, including the role of P2X3 receptors, are driving the development of targeted therapies for improved care. Learn about the effects of RCC recognition and diagnosis on clinical decision-making, current understanding of the pathophysiology of RCC, and advances in targeted therapies through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

RCC Burden and Better Care
Refractory Chronic Cough: Recognizing the Burden and Improving Care
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This educational activity is supported by an independent medical education grant from GSK.

GSK